In 2018, Coformulation of Rilpivirine and Truvada Will Achieve Blockbuster Sales of More Than $2 Billion in the HIV Drug Market

For more information, contact:

Decision Resources

Decision Resources, Inc.

Christopher Comfort

Elizabeth Marshall

781-296-2597

781-296-2563

[email protected]

[email protected]